Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Antipsoriatic dihydrofolate reductase inhibitors available for licensing from BTG

July 22, 1998

Altana offer to license Solarase accepted by Hyal

July 21, 1998

Celgene cleared to market Thalomid in U.S.

July 20, 1998

First demonstration of efficacy for PDT in treating autoimmune disorders

July 17, 1998

Mylan announces copromotion agreement

July 15, 1998

Phase III trial of new foam formulation of clobetasol initiated

July 14, 1998

Dermatological agents in development at Galderma

July 10, 1998

Phase III study shows efficacy of becaplermin treatment for diabetic neuropathic ulcers

July 8, 1998

Dusa submits NDA for Levulan PDT of actinic keratoses

July 6, 1998

Scientifically tested hair loss treatment introduced in Canada

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...